Further, we provide novel evidence that systemic elevation of ApoA‐IV protects against airway hyperresponsiveness, leukocyte infiltration into the airways and reduces eosinophil count in the circulation. This evidence concerns the gene APOA4 and airway hyperresponsiveness.